| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Glibenclamide | Glibenclamide EP Impurity A | VL2470001 | View |
| Glibenclamide | Glibenclamide EP Impurity B | VL2470002 | View CAS 21165-77-5 |
| Glibenclamide | Glibenclamide EP Impurity C | VL2470003 | View CAS 10079-35-3 |
| Catalogue No. | VL2470003 |
| CAS No. | 10079-35-3 |
| Molecular Formula | C22H34N4O4S |
| Molecular Weight | 450.59 |
| Parent drug | Glibenclamide |
| IUPAC Name | N-[4-(β-Cyclohexylureidoethyl)benzensulfonyl] N’-Cyclohexylurea |
| Synonyms | N/A |
| References | Reed, Michael D., and Donald R. Mattison. “Treating the Placenta.” Clinical Pharmacology during Pregnancy, 2013, pp. 73–87, https://doi.org/10.1016/b978-0-12-386007-1.00006-4. |
| Status | In-stock |
| ListName | Glibenclamide EP Impurity C |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
